MGP IngredientsUSANA

MGP Ingredients vs USANA

Destillateur von Spirituosen und Lieferant von Spezialzutaten für Lebensmittel vs US-amerikanischer Hersteller von Nahrungsergänzungsmitteln mit einem Netzwerk unabhängiger Vertriebspartner. Welche Aktie passt im September 2026 besser zu Ihrem Portfolio? Die Antwort in einfacher Sprache finden Sie unten.

MGP Ingredients distills premium American whiskey and industrial alcohol, supplying both branded and private label spirits to a market riding a long craft spirits wave, while USANA distributes nutriti...

Anlageanalyse

Vorteile

  • MGP Ingredients operates across diversified segments including distilled spirits, branded spirits, and ingredient solutions, reducing dependency on a single market.
  • The company’s portfolio includes premium and mid-tier branded spirits, catering to a wide range of consumer preferences and price points.
  • MGP has expertise in producing specialty wheat starches and proteins, positioning it well within growing food ingredient markets.

Zu beachten

  • MGP’s financial performance shows modest stock price movement with no recent significant earnings surprises, indicating potentially limited upside in the short term.
  • The company operates in highly competitive distilled spirits and ingredient markets, which may limit pricing power and margin expansion.
  • Economic cycles and commodity prices, especially grain costs, can adversely affect input costs and operational profitability.
USANA

USANA

USNA

Vorteile

  • USANA Health Sciences showed forecasted revenue growth to approximately $974 million in 2025, with improving EBITDA and net margins indicating operational efficiency gains.
  • The company has a strong market position in science-based nutritional and personal care products, selling via direct and direct-to-consumer channels globally.
  • USANA exhibits a high return on equity around 27%, reflecting effective management and profitable use of shareholders’ equity.

Zu beachten

  • Recent quarterly earnings and revenue fell short of expectations, indicating execution risks and potential volatility in performance.
  • Revenue declined by over 7% in 2024 with a corresponding 34% drop in earnings, showing susceptibility to market pressures or consumer demand shifts.
  • The stock is rated mainly as ‘Hold’ by analysts with limited near-term bullish sentiment, reflecting cautious investor outlook.

MGPI oder USNA in Nemo kaufen

Nemo Logo Fade
🆓

Ohne Provision

Handeln Sie Aktien, ETFs und mehr ohne Provision. Behalten Sie mehr von Ihrer Rendite.

🔒

Vertrauenswürdig & reguliert

Seit 2015 Teil der Exinity Group, mit über einer Million Kunden weltweit.

💰

6 % Zinsen auf Guthaben

Erhalten Sie 6 % Zinsen p.a. auf nicht investiertes Guthaben, mit täglicher Zinsgutschrift.

Häufige Fragen